PMID

Data

Article Title

Organization

Antiinflammatory activity of a series of substituted 2,3-dihydro-6-hydroxypyrimido[2,1-f]purine-4,8(1H,9H)-diones.

Schering-Plough

Synthesis and profile of SCH351591, a novel PDE4 inhibitor.

Schering-Plough

8-Methoxyquinolines as PDE4 inhibitors.

Schering-Plough

Angiotensin converting enzyme inhibitors: spirapril and related compounds.

Schering-Plough

Synthesis and pharmacological activity of angiotensin converting enzyme inhibitors: N-(mercaptoacyl)-4-substituted-(S)-prolines.

Schering-Plough

Selectively nonselective kinase inhibition: striking the right balance.

Schering-Plough

Dioxo-triazines as a novel series of cathepsin K inhibitors.

Schering-Plough

Design and optimization of a series of novel 2-cyano-pyrimidines as cathepsin K inhibitors.

Schering-Plough

Synthesis and receptor affinities of some conformationally restricted analogues of the dopamine D1 selective ligand (5R)-8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl- 1H-3-benzazepin-7-ol.

Schering-Plough

Dual antagonists of platelet activating factor and histamine. Identification of structural requirements for dual activity of N-Acyl-4-(5,6-dihydro-11H-benzo [5,6]cyclohepta-[1,2-b]pyridin-11-ylidene)piperidines.

Schering-Plough

C-ring modified tricyclic benzonaphthiridinone protein kinase inhibitors and use thereof

Merck Patent

Identification of a new JNK inhibitor targeting the JNK-JIP interaction site.

Burnham Institute For Medical Research